These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 10558410

  • 1. Agency information collection activities; announcement of OMB approval; Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar 25; 64(57):14451. PubMed ID: 10558410
    [Abstract] [Full Text] [Related]

  • 2. Agency information collection activities; announcement of OMB approval; medical devices: third-party review program under the U.S./EC MRA. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar 08; 64(44):11018. PubMed ID: 10557621
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Jun 25; 72(121):34751-958. PubMed ID: 17674484
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Maintaining a level playing field: the need for a uniform standard to evaluate health claims for foods and dietary supplements.
    Pappas CD.
    Food Drug Law J; 2002 Jun 25; 57(1):25-41. PubMed ID: 12118479
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Supplements facts versus all the facts. What the new label does and doesn't disclose.
    Czap A.
    Altern Med Rev; 1999 Feb 25; 4(1):5-9. PubMed ID: 9988778
    [No Abstract] [Full Text] [Related]

  • 11. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
    McNamara SH.
    Food Drug Law J; 1999 Feb 25; 54(1):35-42. PubMed ID: 11758558
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Interim final rule; notice of extension of period for issuance of final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2001 Jun 06; 66(109):30311-3. PubMed ID: 11724074
    [Abstract] [Full Text] [Related]

  • 15. Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #1; availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar 19; 64(53):13590-1. PubMed ID: 10558407
    [Abstract] [Full Text] [Related]

  • 16. To suppress is human, to disclaim divine.
    Czap A.
    Altern Med Rev; 1999 Feb 19; 4(1):3-4. PubMed ID: 9988777
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body; partial stay of compliance. Food and Drug Administration, HHS. Final rule; partial stay of compliance.
    Fed Regist; 2000 Sep 29; 65(190):58346-50. PubMed ID: 11503646
    [Abstract] [Full Text] [Related]

  • 20. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE, Taylor DA.
    J Pharmacol Exp Ther; 2005 Sep 29; 314(3):939-44. PubMed ID: 15833895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.